Search
for
Sort by
Research 331–360 of 1000+
- Treatment options for alopecia: an update, looking to the future
- Aromatic plants as cosmeceuticals: benefits and applications for skin health
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review
- Lanostane-type triterpenes from the sclerotium of Inonotus obliquus (Chaga mushrooms) as proproliferative agents on human follicle dermal papilla cells
- Evaluation of ovarian reserve and function in female patients treated with oral isotretinoin for severe acne: an exploratory study
- Clinico-investigative profile of patients of hirsutism in a tertiary level institution
- Dermatosis associated with menopause
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Androgen Receptor Ligands: Agonists and Antagonists
- Pharmacological Treatment of Alopecia
- Caring for women with polycystic ovary syndrome
- Prostate-specific antigen as a diagnostic marker in female hyperandrogenism
- Herbal Formulation for Hair Growth Promotion and Scalp Health
- Effects of High-dose Radioactive Iodine Therapy on Hormonal Profiles and Sperm Quality in Thyroidectomy Patients
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Management of teenagers with polycystic ovarian syndrome
- Gender Differences in Production and Circulating Levels of Sex Hormones and Their Impact on Aging Skin
- Androgen Secreting Steroid Cell Tumor of the Ovary Represented with Postmenopasal Bleeding and Extensive Hirsutism
- 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Alopecia and hirsutism*
- Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Endocrinology of Transgender Medicine
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity